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Recruitment to telomeres is a pivotal step in the function and regulation of human telomerase; however, the
molecular basis for recruitment is not known. Here, we have directly investigated the process of telomerase
recruitment via fluorescence in situ hybridization (FISH) and chromatin immunoprecipitation (ChIP). We find that
depletion of two components of the shelterin complex that is found at telomeres—TPP1 and the protein that tethers
TPP1 to the complex, TIN2—results in a loss of telomerase recruitment. On the other hand, we find that the
majority of the observed telomerase association with telomeres does not require POT1, the shelterin protein that
links TPP1 to the single-stranded region of the telomere. Deletion of the oligonucleotide/oligosaccharide binding
fold (OB-fold) of TPP1 disrupts telomerase recruitment. In addition, while loss of TPP1 results in the appearance
of DNA damage factors at telomeres, the DNA damage response per se does not account for the telomerase
recruitment defect observed in the absence of TPP1. Our findings indicate that TIN2-anchored TPP1 plays a major
role in the recruitment of telomerase to telomeres in human cells and that recruitment does not depend on POT1
or interaction of the shelterin complex with the single-stranded region of the telomere.
The physical ends of eukaryotic chromosomes, termed telo-
meres, are maintained by the cellular reverse transcriptase
telomerase. Telomerase uses an internal RNA moiety as a
template to add short telomeric repeats to the 3 ends of
chromosomes (18, 32). Telomeres protect chromosomes from
nucleolytic degradation and inappropriate DNA repair reac-
tions (38). In humans, telomerase is developmentally regulated
and is expressed primarily during the first weeks of embryo-
genesis (10). Later in life, most normal human somatic cells
express only very low levels of telomerase, and telomeres
shorten with continuous cell division cycles due to the end
replication problem and nucleolytic processing of chromosome
ends. Upon reaching a critical length, short telomeres activate
a DNA damage response that leads to a permanent cell cycle
arrest or apoptosis (15). Reactivation of telomerase is a key
requisite for human cancer cells to attain unlimited prolifera-
tion potential (7). Telomere shortening suppresses tumor for-
mation, but at the same time, the telomere reserve must be
long enough to allow tissue renewal by healthy cells during the
entire life span (27). Indeed, accelerated telomere shortening
causes dyskeratosis congenita, a bone marrow failure syn-
drome that leads to premature death due to aplastic anemia
(47). Telomere dysfunction has also been linked to the patho-
genesis of idiopathic pulmonary fibrosis (2), ICF syndrome
(55), and Werner syndrome (11).
The maturation and activity of telomerase depend on sub-
cellular trafficking. A minimal, catalytically active telomerase
enzyme (that can add telomeric repeats to the ends of DNA
oligonucleotide substrates in vitro) can be formed by the
telomerase reverse transcriptase (TERT) and the telomerase
RNA moiety (TR) (3, 49). However, the human TERT
(hTERT)-hTR core complex is not competent for telomere
elongation in vivo. Within cells, hTR accumulates in Cajal
bodies (CBs), subnuclear structures that also contain the sub-
set of box H/ACA pseudouridylation guide RNAs termed
small CB-specific RNAs (scaRNAs), which modify snRNAs
(22, 56). hTR accumulation in Cajal bodies is not needed for
assembly of the catalytic core of telomerase but is required to
render telomerase competent for telomere association and ex-
tension in vivo (12, 46). The telomerase holoenzyme subunit
TCAB1 (telomerase Cajal body factor 1) mediates the essen-
tial CB localization step (46). Telomere synthesis occurs during
S phase, and hTR localizes to telomeres specifically during this
phase of the cell cycle (23, 44). However, factors that function
in the recruitment of telomerase to telomeres are not known.
The six-component telomere capping complex termed shel-
terin is important for telomere length control in vivo (38, 51),
suggesting potential roles for the complex in the regulation of
telomerase access to telomeres. Interestingly (and perplex-
ingly), current evidence suggests that shelterin components can
both inhibit and stimulate telomere elongation. The six shel-
terin components are TRF1, TRF2, RAP1, TIN2, POT1, and
TPP1 (16, 51) (Fig. 1A). The shelterin complex associates with
the double-stranded region of the telomere through direct
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interactions of TRF1 and TRF2 with the DNA (8, 16). POT1
binds the single-stranded region of the telomere (6, 29). De-
pletion of TRF1 leads to telomere elongation, and overexpres-
sion of TRF1 causes telomere shortening in human telomerase-
positive cells without affecting in vitro-assayed telomerase
activity (41), suggesting that reinforcement of the shelterin
complex inhibits telomerase function. Similarly, depletion of
TPP1 by RNA interference (RNAi) or disruption of the TPP1-
FIG. 1. TPP1 depletion results in loss of localization of telomerase to telomeres (assessed by FISH). (A) Mammalian chromosome end
structure is regulated by a complex of six core telomere-associated proteins (indicated) that make up the shelterin complex (16, 51). TPP1 is
associated with the double-stranded and single-stranded portion of telomeres via direct interactions with TIN2 and POT1, respectively (16, 51).
(B) Fluorescence in situ hybridization (FISH) was used to detect hTR (red), and immunofluorescence (IF) was used to detect TRF2 (telomere
marker, green) and hTERT (blue) or coilin (Cajal body marker, blue) in parental () and TPP1-depleted () super-telomerase HeLa cells. Cells
were imaged by fluorescence microscopy. Merge panels in all microscopy figures show superimposition of the individual panels. A subset of hTR
(hTERT) colocalizations with telomeres is indicated with arrowheads. Scale bars in all microscopy panels represent 10 m. (C) The average
number of hTR-telomere associations per cell (one focal plane) detected by FISH/IF in parental and TPP1-depleted cells represented in panel B
is shown. Error bars in plots of localization data in all figures indicate standard errors (see Materials and Methods). (D) Parental () and
TPP1-depleted () HeLa cells (no exogenous telomerase expression) were synchronized to mid-S phase during drug selection. hTR (red) and
telomeres (green) were detected by FISH. hTR colocalizations with telomeres are indicated with arrowheads. (E) The average number of
hTR-telomere associations per cell (one focal plane) detected by FISH/IF in parental and TPP1-depleted cells represented in panel D is shown.
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POT1 interaction (which are both accompanied by loss of the
POT1 signal at telomeres) also results in telomere lengthening
(33, 54). At the same time, however, several findings support
positive roles of shelterin in telomere length regulation. In
particular, TPP1 together with POT1 has been shown to im-
prove telomerase activity and processivity in vitro (48) by slow-
ing primer dissociation and aiding telomerase translocation
(28). Dissection of the apparently opposing roles of the shel-
terin complex components in telomerase function awaits fur-
ther investigation.
TPP1 has been hypothesized to play a role specifically in the
recruitment of telomerase to telomeres based on its association
with telomerase (52). Xin et al. demonstrated that tandem
affinity purification (TAP)-tagged hTERT and glutathione S-
transferase (GST)-tagged TPP1 copurify when fractionated
from cellular extracts derived from cells coexpressing the
tagged proteins (52). In addition, both GST-tagged TPP1 and
the oligonucleotide/oligosaccharide binding fold (OB-fold) of
TPP1 pull down in vitro-translated hemagglutinin (HA)-tagged
TERT and telomerase activity (52), indicating that the TPP1
OB-fold is important for association of TPP1 with telomerase.
It is not clear whether the interaction between TPP1 and
hTERT is direct. These studies did not examine recruitment of
telomerase to telomeres. However, based on their findings, the
authors speculated that TPP1 together with POT1 could play a
role in positively (and negatively) regulating access of telo-
merase to telomeres (52).
In this work, we have directly investigated the process of
telomerase recruitment using fluorescence in situ hybridization
(FISH) and immunofluorescence (IF) in parallel with quanti-
tative chromatin immunoprecipitation (ChIP) to monitor the
association of hTR and hTERT with telomeres. We find that
short hairpin RNA (shRNA)-mediated depletion of TPP1 and
TIN2, but not POT1, significantly reduces the presence of
telomerase at telomeres. Our findings reveal that TPP1 bound
to telomeres via TIN2 plays a key role in the accumulation of
telomerase at telomeres.
MATERIALS AND METHODS
Plasmids. shRNA vectors were prepared by cloning double-stranded DNA
oligonucleotides into pSuper-Puro (4). The target sequences were as follows:
TPP1, 5-GACUUAGAUGUUCAGAAAA-3; TIN2, 5-GTGGAACATTTTC
CGCGAGTACTGGAGT-3 (53); and POT1, 5-GTACTAGAAGCCTATCTC
A-3 (shRNA 1) and 5-GGGTGGTACAATTGTCAAT-3 (shRNA 2). Full-
length TPP1, TPP1 lacking the OB-fold (TPP1OB) (52), and full-length TPP1
bearing two silent mutations in the shRNA target site (1575 A3G and 1581
T3A) were eptitope tagged (N-terminal and C-terminal 3Flag from Sigma)
and expressed from pcDNA6 (Invitrogen).
Cell culture and transfection. Super-telomerase HeLa cells were generated as
described previously (13). Cells were transfected using Lipofectamine 2000 ac-
cording to the manufacturer’s protocol (Invitrogen). Puromycin (1 g/ml)
(InvivoGen) was added to the medium 24 h after transfection of pSuper-Puro
derivatives. Puromycin selection was maintained until mock-transfected cells
were dead (approximately 3 days). For TPP1 shRNA- and TIN2 shRNA-treated
cells, ChIP analysis was performed 4 days posttransfection. POT1 shRNA-
treated cells were analyzed 6 days posttransfection.
For FISH and IF, HeLa cells and super-telomerase HeLa (13) cells were
grown on coverslips in Dulbecco modified Eagle medium (DMEM) (Fisher
Scientific, Pittsburgh, PA) supplemented with 10% fetal bovine serum (FBS)
(Fisher Scientific). All cells were cultured at 37°C with 5% CO2. Transfections
were carried out using Lipofectamine 2000 transfection reagent, according to the
manufacturer’s protocol (Invitrogen, Carlsbad, CA). Cells were selected in 1
g/ml puromycin (Sigma-Aldrich) for 48 h following transfection. In some cases,
cells were synchronized to mid-S phase using double thymidine block as previously
described (44) except that 18-h thymidine treatments were used. (Cells were released
for 9 h between thymidine treatments.) Bromodeoxyuridine (BrdU) labeling was
performed as described previously (44) to confirm S-phase synchronization.
Fluorescence in situ hybridization (FISH) and immunofluorescence (IF).
Three DNA probes (probes 1, 2, and 3), complementary to different regions of
telomerase RNA, were used in hTR FISH (44). A fourth DNA probe, comple-
mentary to the G-rich strand of the telomere (CT*AACCCTAACCCT*AACC
CTAACCCT*AACCCTAACCCT*AACCCTAACCCT*A [T* indicates amino-
allyl-modified thymidines]), was synthesized by Qiagen (Valencia, CA) and used
to detect telomeres. Probes were conjugated with Cy3 or Oregon green mono-
functional reactive dye according to the manufacturer’s protocol (GE Health-
care, Little Chalfont, Buckinghamshire, United Kingdom; Invitrogen). A 25-ng
portion of each Cy3-labeled hTR FISH probe and/or 0.2 ng of telomere FISH
probe was used per coverslip. FISH was performed essentially as described
previously (44). However, when hTR FISH was performed in combination with
BrdU or telomere FISH, the cells were subjected to a 10-min denaturation at
85°C in 70% formamide, 2 SSC (1 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate) prior to FISH.
Following FISH, cells were analyzed by IF as described previously (44). Cells
were washed three times with 1 phosphate-buffered saline (PBS) and blocked
for 1 h in 0.05% Tween-20 in PBS (PBS-T) or 3% bovine serum albumin (BSA)
in PBS. Next, cells were incubated with one of several combinations of the
following primary antibodies at the indicated dilution for 1 h at room tempera-
ture: mouse anti-p80 coilin (1:5,000, ) (1), mouse anti-TRF2 (1:1,000; Imgenex
Corp., San Diego, CA), rabbit anti-hTERT (1:400; Rockland, Gilbertsville, PA),
mouse anti-FLAG (1:500; Sigma-Aldrich, St. Louis, MO), rabbit anti-RAP1(1:
2,000; Novus Biologicals, Littleton, CO), and rabbit anti-53BP1(1:500; Bethyl,
Montgomery, TX). Cells were washed three times in 1 PBS and then incubated
with secondary antibody (1:100 Cy2-conjugated goat anti-rabbit IgG [HL],
1:100 Cy2-conjugated goat anti-mouse IgG [HL], 1:100 Cy5-conjugated goat
anti-mouse IgG, 1:100 Cy5-conjugated goat anti-rabbit IgG [HL], 1:100
7-amino-4-methylcoumarin-3-acetic acid [AMCA]-conjugated goat anti-mouse
IgG [HL], or 1:100 AMCA-conjugated goat anti-rabbit IgG [HL]) (all from
Jackson ImmunoResearch Laboratories, West Grove, PA) for 1 h at room
temperature. Primary antibodies were diluted in PBS-T or 3% BSA in PBS, while
secondary antibodies were diluted in PBS-T only. Cells were subjected to three
final 1 PBS washes and mounted in Prolong Gold (Invitrogen).
Microscopy. Slides were analyzed using a Zeiss Axioskop 2 Mot Plus fluores-
cence microscope (Carl Zeiss Microimaging, Thornwood, NY). Images were
acquired at 63 (Plan Apochromat objectives; numerical aperture, 1.4) using a
cooled charge-coupled-device ORCA-ER digital camera (Hamamatsu Photon-
ics, Bridgewater, NJ) and IPLab Spectrum software (BioVision Technologies,
Inc., Exton, PA). Linear image adjustments were made when necessary using
Adobe Photoshop and applied simultaneously to image groups. The colors de-
picted in the figures do not necessarily correspond to the “colors” of the fluo-
rescent labels used in the experiment. All data are collected in gray scale and
converted to the indicated colors using IPLab Spectrum and/or Adobe Photo-
shop software. Representative cells are shown in all microscopy figure panels.
For quantitation of 53BP1 and POT1 IF data, images from treatment groups
were normalized (to the same maximum) before analysis. Plots of average num-
bers of colocalizations observed per cell (one focal plane) show data obtained
from 8 to 12 fields of cells for each treatment group processed in parallel on the
same day. Error bars indicate standard errors calculated with N equal to the
number of fields quantitated.
Chromatin immunoprecipitation. ChIP assays were performed as described
previously (13), with the following modifications. For immunoprecipitations, 25
l of hTERT R484 rabbit serum (50), 2.5 g mouse monoclonal TPP1 antibody
(ACD; Abnova H00065057-M02), or 2 g mouse monoclonal H2AX antibody
(Millipore 05-636) was used, and the mixtures were incubated for 6 h at 4°C with
50 l of a 50% slurry of protein A/G-Sepharose beads (GE Healthcare). Telo-
meric DNA was detected as described previously (5). For detection of Alu
sequences, a 5 32P-labeled oligonucleotide probe (5-GTGATCCGCCCGCCT
CGGCCTCCCAAAGTG-3) was used.
qRT-PCR. Total RNA was isolated using TRIzol reagent (Invitrogen). The
isolated RNA fraction was treated with RNase-free DNase (Qiagen) and repu-
rified with the TRIzol LS reagent (Invitrogen). For quantitative reverse trans-
criptase PCR (qRT-PCR), cDNA was prepared from 2 g total RNA, using
random primers and SuperScript III reverse transcription (Invitrogen) followed
by qPCR on a 7900HT fast real-time PCR system (Applied Biosystems), using
the PowerSYBR Green PCR master mix (Applied Biosystems). For PCR am-
plification of TIN2 cDNA, forward and reverse primers were 5-GTCAGAGG
CTCCTGTGGATT-3 and 5-CAGTGCTTTCTCCAGCTGAC-3, respective-
ly; POT1 cDNA was amplified with previously described primers (26). Serial
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dilutions of TIN2 and POT1 cDNAs were used to determine amplification efficien-
cies. TIN2 and POT1 quantities were normalized to the level of 	-actin cDNA.
Immunoblots. A total of 5  104 cells (or 1  104 cells for FLAG immuno-
blots) were boiled for 5 min in Laemmli loading buffer and fractionated on 4 to
20% SDS-polyacrylamide gradient gels (Lonza) except for TIN2 (10% poly-
acrylamide gel) and POT1 (8% polyacrylamide gel). Standard immunoblot pro-
tocols were used with the following antibodies: mouse monoclonal TPP1 anti-
body, ACD Abnova H00065057-M02 (1:1,000); rabbit polyclonal TIN2C
701 antibody, a kind gift from S. Smith (1:1,000); rabbit polyclonal hPOT1
978 antibody, a kind gift from T. de Lange (1:1,000); rabbit polyclonal hTERT
antibody, Rockland 600-401-252 (1:2,500); rabbit polyclonal CENP-A antibody,
Upstate 07-240 (1:2,000); mouse monoclonal -H2AX antibody, Millipore 05-
636 (1:2,000); and mouse monoclonal FLAG M2 antibody, Sigma F3165 (1:
5,000). For POT1 immunoblots, guanidine renaturation was performed as de-
scribed previously (34). Secondary horseradish peroxidase-conjugated goat
antibodies against rabbit or mouse IgG (1:3,000; Promega) were used to reveal
the primary antibodies. The AlphaInnotech chemiluminescence substrate and
imaging system was used for signal detection and quantification.
Coimmunoprecipitation. Coimmunoprecipitation of endogenous TPP1 and
POT1 proteins was performed in super-telomerase HeLa cells transfected with two
different shRNAs against POT1. Precleared cell lysates from 106 cells were prepared
as previously described (34). Lysates were immunoprecipitated with 10 g mouse
monoclonal TPP1 antibody ACD Abnova H00065057-M02, and immune complexes
were bound to a 50% slurry of protein G-Sepharose beads. After an overnight
FIG. 2. Depletion of TPP1, TIN2, and POT1. (A) Immunoblot analysis of TPP1-depleted cells. Super-telomerase HeLa cells were transfected
with pSuper-Puro (vector) or pSuper-Puro-TPP1 shRNA vector (shTPP1). Four days after transfection, TPP1, hTERT, TIN2, and CENP-A
expression was analyzed by immunoblotting. The arrowheads indicate the position of endogenous TPP1 protein. Asterisks indicate nonspecific
bands. CENP-A was used as a loading control. (B) Immunoblot analysis of TIN2-depleted cells. Four days after transfection, protein expression
was analyzed as described for panel A. (C) qRT-PCR analysis of TIN2-depleted cells. qRT-PCR detection of mRNA levels of TIN2 in
super-telomerase HeLa cells, 4 days after transfection with TIN2-shRNA, relative to empty-vector control. Error bars correspond to standard
deviations of results of three independent experiments. Statistical analyses were done using a two-tailed Student’s t test (**, P 
 0.01).
(D) Immunoblot analysis of POT1-depleted cells. Six days after transfection, protein expression was analyzed as described for panel A.
(E) qRT-PCR analysis of POT1-depleted cells. qRT-PCR showing mRNA levels of POT1 in super-telomerase HeLa cells, 6 days after transfection
with two different POT1-shRNAs, relative to empty-vector control. Error bars correspond to standard deviations of results of two independent
experiments. (F) IP/immunoblot analysis of POT1-depleted cells. Coimmunoprecipitation of endogenous POT1 with TPP1 in POT1-depleted cells.
TPP1-immunoprecipitated complexes from super-telomerase HeLa cells transfected with the indicated plasmids were resolved by 8% SDS-PAGE.
Immunoblot antibodies are indicated on the left. No detection of TPP1 was observed in the supernatant fraction after IP (data not shown). A
nonspecific band recognized by the TPP1 antibody in the IP fraction (**) served as a loading control. (G) Direct IF analysis of POT1-depleted
cells. POT1 (red) and TRF2 (green) were detected by IF in parental () and POT1-depleted cells.
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incubation at 4°C, beads were washed four times with lysis buffer (34) and proteins
were eluted with Laemmli loading buffer for analysis by 8% SDS-PAGE.
Real-time quantitative telomeric repeat amplification protocol (RQ-TRAP).
Telomerase activity was measured as previously described (13), with the follow-
ing modifications. Reaction mixtures containing the PowerSYBR Green PCR
master mix (Applied Biosystems), 1.8 g undiluted or 3-fold-diluted cell extracts,
1 M telomerase primer TS, 0.3 M reverse primer ACX, and 0.5 mM MgCl2
were incubated for 30 min at 30°C and for 10 min at 95°C. Using the 7900HT fast
real-time PCR System (Applied Biosystems), samples were amplified in 40 PCR
cycles for 15 s at 95°C and 1 min at 60°C. Threefold serial dilutions of the
empty-vector-transfected samples were used to obtain a standard curve of the
form log10 (protein quantity)  aCT  b, where CT is the threshold constant, a
is the slope of the curve, and b is the y intercept. Telomerase activity was
expressed relative to this standard as the quantity of standard sample extract
giving the same CT value. All samples were serially diluted to verify the linearity
of the RQ-TRAP reaction and heat inactivated to verify that the amplification
product was attributable to telomerase activity.
RESULTS
TPP1 depletion results in loss of association of telomerase
with telomeres. The recruitment of telomerase to telomeres is
essential for telomere maintenance; however, the mechanism
of recruitment is not known. Association of telomerase with
telomeres can be observed in cancer cells during S phase by
FISH with oligonucleotide probes complementary to hTR or
IF with hTERT antibodies (12, 22, 23, 43, 44, 46, 56). Analysis
of telomerase recruitment is facilitated by the use of so-
called super-telomerase cells, which concomitantly overexpress
hTERT and hTR, allowing detection of telomerase association
with telomeres by ChIP as well as by microscopy in all phases
of the cell cycle (12, 13). In order to identify proteins that are
necessary for recruitment of telomerase to telomeres, we
depleted candidate recruitment factors using shRNAs in su-
per-telomerase HeLa cells and examined the localization of
telomerase by FISH and ChIP analysis. We found that shRNA-
induced depletion of the shelterin component TPP1 (Fig. 2A)
caused a striking loss of telomerase localization to telomeres as
assessed by FISH (Fig. 1) and ChIP (Fig. 3).
In untreated super-telomerase cells, hTR (visualized by
FISH) is found at the Cajal bodies (visualized via the Cajal
body marker protein coilin) and numerous telomeres (visual-
ized via the telomere-binding protein TRF2) (Fig. 1B,
shTPP1; a subset of the hTR-telomere colocalizations is in-
dicated with arrowheads). Following TPP1 depletion, hTR re-
mains at Cajal bodies but is found only at very few telomeres
(Fig. 1B and C, shTPP1). TPP1 depletion reduced the num-
ber of observed hTR-telomere colocalizations by 77%, from a
mean of 3.5  0.3 (standard error of the mean [SEM]) colo-
calizations per cell (one focal plane) in parental super-telo-
merase cells to 0.8  0.1 (SEM) after TPP1 depletion (Fig.
1C). hTERT localization to telomeres was also noticeably re-
duced by depletion of TPP1 (Fig. 1B, lower panels; a subset of
hTR-hTERT-telomere colocalizations is indicated with arrow-
heads). At the same time, progression through the cell cycle
(assessed by percentage of cells found in S phase), cellular
telomerase levels (assayed in vitro by RQ-TRAP), and hTERT
protein levels (assayed by immunoblot analysis) were not af-
fected by TPP1 depletion (Fig. 2A and data not shown). These
results suggest that TPP1 is necessary for the recruitment of
telomerase from Cajal bodies to telomeres in super-telomerase
cells. Importantly, TPP1 depletion results in a similar loss of
hTR localization to telomeres during S phase in standard
HeLa cells (not expressing exogenous telomerase) (Fig. 1D
and E; telomeres are detected with a DNA probe; a subset of
hTR-telomere colocalizations is indicated with arrowheads).
TPP1 depletion reduced the number of hTR-telomere colocal-
izations by 68%, from a mean of 0.41  0.16 (SEM) per cell to
0.13  0.08 (SEM) after TPP1 depletion (Fig. 1E).
We also examined telomerase recruitment to telomeric
DNA by ChIP in super-telomerase HeLa cells (Fig. 3). ChIP
relies on formaldehyde-mediated covalent linkage of proteins
to DNA and therefore reflects close physical as well as spatial
FIG. 3. TPP1 depletion results in loss of physical association of
hTERT with telomeres (assessed by ChIP). (A) ChIP of telomeric and
Alu DNA with TPP1-specific (A) and hTERT-specific (B) antibodies
in super-telomerase HeLa cells. The percentage of telomeric and Alu
DNA recovered in each ChIP is indicated. Error bars correspond to
standard deviations of results of three (hTERT ChIP) and five (TPP1
ChIP) independent experiments. Statistical analyses were done using a
two-tailed Student’s t test (, P 
 0.001; , P 
 0.01).
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associations of proteins and DNA. TPP1 was depleted (Fig. 2),
and the association of telomerase with telomeres (and Alu
repeats) was assessed by IP with hTERT antibodies. As ex-
pected, little telomeric DNA was immunoprecipitated with
TPP1 antibodies upon depletion of TPP1 (Fig. 3A). In addi-
tion, however, immunoprecipitation of telomeric DNA with
hTERT antibodies was reduced by 36% when cellular TPP1
was depleted (Fig. 3B). The small degree of association of
hTERT observed with Alu-repeat DNA, which served as a
negative control, was not affected by TPP1 depletion. Thus,
both FISH and ChIP analyses implicate TPP1 as a telomerase
recruitment factor.
POT1 is not required for association of telomerase with
telomeres, but depletion of TIN2 results in reduced associa-
tion. TPP1 interacts with telomeres via two proteins: TIN2,
which binds to the double-stranded telomere-bound TRF1 and
TRF2 proteins, and POT1, which mediates interaction with the
single-stranded region of the telomere (16, 51) (see Fig. 1A).
We found that TPP1 depletion reduced TIN2 protein levels
(Fig. 2A), suggesting that the recruitment defect that we ob-
FIG. 4. Telomerase recruitment depends on TIN2 but not POT1. (A) ChIP of telomeric and Alu DNA with hTERT antibody. (B) Quantifi-
cation of ChIP data shown in panel A. Error bars correspond to standard deviations of results of three (TIN2 data) and two (POT1 data)
independent experiments. Statistical analyses were done using a one-tailed Student’s t test (*, P 
 0.05). (C) hTR (red) was detected by FISH and
TRF2 (green) and coilin (blue) were detected by IF in parental () and POT1- or TIN2-depleted cells. hTR colocalizations with telomeres are
indicated with arrowheads. (D and E) The average number of hTR-telomere associations per cell (one focal plane) detected by FISH/IF in parental
and POT1- or TIN2-depleted cells represented in panel C is shown.
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served in TPP1-depleted cells may require TIN2. At the same
time, a current model suggests that TPP1 functions with POT1
to recruit telomerase to telomeres (52). To further investigate
the mechanism of TPP1-mediated telomerase recruitment, we
depleted TIN2 or POT1 using shRNAs (Fig. 2B to G). ChIP
analysis indicated that association of hTERT with telomeres
was reduced 43% upon depletion of TIN2 (Fig. 4A and B),
similar to the reduction observed with TPP1 depletion (Fig. 3).
However, immunoblot analysis revealed that depletion of
TIN2 also resulted in a reduction in TPP1 protein levels (but
not telomerase activity or hTERT protein levels) (Fig. 2B and
data not shown). On the other hand, POT1 depletion did not
detectably change TPP1 levels (Fig. 2D). In addition, POT1
depletion did not disrupt hTERT association with telomeres in
ChIP analysis (Fig. 4A and B).
FISH analysis of hTR also showed a marked difference in the
effects of TIN2 and POT1 depletion. hTR-telomere colocaliza-
tion with TIN2 depletion was reduced to an extent similar to that
observed with TPP1 depletion (Fig. 4C and D). Following TIN2
depletion, hTR-telomere colocalizations decreased by 69%, from
a mean of 3.5  0.3 (SEM) per cell to 1.1  0.3 (SEM) per cell
(Fig. 4D). However, POT1 depletion did not reduce the colocal-
ization of hTR with telomeres (Fig. 4C and E). The results indi-
cate that POT1 and association with the single-stranded region of
the telomere (see Fig. 1A) are not required for the association of
the majority of telomerase with telomeres and suggest a role for
TIN2-tethered TPP1 in recruitment.
The OB-fold of TPP1 is required for association of telo-
merase with telomeres. In order to further investigate the
function of TPP1 in telomerase recruitment, we rescued the
shRNA-mediated depletion of endogenous TPP1 by expres-
sion of FLAG epitope-tagged TPP1. Control (empty vector)
and rescue (TPP1) plasmids were cotransfected along with the
TPP1 shRNA-encoding plasmid. Expression of endogenous
and exogenous TPP1 was assessed by immunoblot analysis with
TPP1 and FLAG antibodies 4 days following transfection (Fig.
5A). The reduction in association of telomerase with telomeres
observed with TPP1 depletion by ChIP analysis was not res-
cued by expression of an shRNA-sensitive TPP1 gene (Fig. 5B
and C); in both cases, the telomeric DNA precipitated with
hTERT antibody was approximately 50% of the shRNA-neg-
ative control. However, expression of an shRNA-resistant
TPP1 gene (TPP1*, shRNA mRNA recognition site destroyed
without altering the protein sequence) encoding full-length
FLAG-tagged TPP1 fully restored telomerase association, in-
dicating that the phenotype is related to TPP1 depletion. In
order to test the potential role of the N-terminal OB-fold
domain of TPP1 (required for coprecipitation of telomerase
and TPP1 in pulldown experiments) (52) in recruitment to
telomeres, we introduced an shRNA-resistant truncated ver-
sion of TPP1 (TPP1OB*). TPP1 lacking the OB-fold did not
rescue telomerase recruitment assessed by ChIP (Fig. 5B
and C).
At the cellular level, we also observed that cotransfection of
shRNA-resistant full-length TPP1 (TPP1*) restored localiza-
tion of hTR to telomeres (localized via telomere-binding pro-
tein TRF2 or RAP1) (Fig. 6A). The FLAG-tagged TPP1 lo-
calized to telomeres, including those where hTR was found
(Fig. 6A; see arrowheads, TPP1*). Expression of the shRNA-
resistant TPP1 increased the number of hTR-telomere colo-
calizations from a mean of 0.7  0.1 (SEM) per cell, observed
in TPP1-depleted cells, to 2.4  0.4 (SEM) per cell, similar to
the 2.1  0.3 (SEM) colocalizations per cell observed in pa-
rental super-telomerase cells in this experiment (Fig. 6B). On
the other hand, TPP1 lacking the OB-fold domain was unable
to rescue telomerase recruitment (0.3  0.1 [SEM] hTR-telo-
mere colocalizations per cell) (Fig. 6B), despite the fact that
the TPP1OB protein localized to telomeres (see FLAG and
RAP1 in Fig. 6A). These results suggest that the association of
FIG. 5. Human telomerase is recruited to telomeres via the OB-fold
of TPP1. (A) Immunoblot analysis of ectopically expressed FLAG
epitope-tagged full-length TPP1 (TPP1), FLAG-tagged, shRNA-resistant
full-length TPP1 (TPP1*), and FLAG-tagged, shRNA-resistant TPP1
lacking the OB-fold (TPP1OB*). Super-telomerase HeLa cells were
cotransfected with the indicated plasmids, and protein expression was
analyzed 4 days after transfection. Black arrowheads indicate the presence
of the respective TPP1 proteins, and white arrowheads indicate the lack of
expression. Immunoblots were probed with anti-TPP1, anti-FLAG and
CENP-A antibodies as indicated. (B) ChIP of telomeric and Alu DNA
with hTERT antibody from cells in panel A. (C) Quantification of data in
panel B representing percentage of telomeric and Alu DNA recovered in
hTERT ChIP. Error bars correspond to standard deviations of results of
four independent experiments. Statistical analyses were done using a
two-tailed Student’s t test (*, P 
 0.05).
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TPP1 and telomerase, which is mediated by the OB-fold of
TPP1 (52), functions in recruitment of telomerase to telo-
meres.
TIF formation does not impair association of telomerase
with telomeres. Previous studies demonstrated that depletion
of TPP1 activates a DNA damage response marked by the
formation of telomere dysfunction-induced foci (TIFs) at telo-
meres (19, 20, 52). TIF formation can be detected via the
association of DNA damage proteins, such as -H2AX and
53BP1, with telomeres (42). Accordingly, our ChIP analysis of
telomeric DNA with antibodies against the DNA damage
marker -H2AX revealed a 7-fold increase in -H2AX at telo-
meres when TPP1 levels are reduced (Fig. 7A and B) (without
a detectable change in cellular -H2AX levels; Fig. 7C). In
addition, we found the DNA damage marker 53BP1 at telo-
meres in 29%  8% (SEM) of cells by IF when TPP1 was
depleted, relative to 0.4%  0.4% (SEM) of untreated cells in
our experiments (Fig. 7D) (scoring threshold  7 or more
53BP1-telomere colocalizations per cell, similar to that used by
others [17, 24]). These findings support the previous observa-
tions of TIF formation in response to TPP1 depletion and
suggest general effects of TPP1 knockdown on telomere com-
position that could lead to the observed loss of telomerase
recruitment. However, additional observations indicate that
TIF formation per se does not account for the loss of telo-
merase recruitment observed in the absence of TPP1.
FIG. 6. The TPP1 OB-fold is required to rescue telomerase recruitment to telomeres. An shRNA-resistant form of TPP1 is able to restore hTR
localization to telomeres in TPP1-depleted cells. However, an shRNA-resistant form of TPP1 lacking the OB-fold cannot restore localization.
(A) Parental and TPP1-depleted super-telomerase HeLa cells were subjected to FISH and IF to detect hTR (red), coilin (blue), and TRF2 (green).
Merge panels show superimposition of hTR, coilin, and TRF2. Next, parental cells were cotransfected with shTPP1 and either TPP1* or
TPP1OB*. Treated cells were subjected to FISH and IF to detect hTR (red), FLAG (blue), and RAP1 (telomere marker, green). Merge panels
show superimposition of hTR, FLAG, and RAP1. (B) Plot of the average number of telomere-associated hTR foci per cell in the parental cells
and each experimental group. Error bars indicate standard errors calculated with N equal to the number of samples quantitated.
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Depletion of POT1 (and TIN2) also leads to a DNA damage
response at telomeres (21, 25), evidenced by an increase in
-H2AX association with telomeric DNA by ChIP analysis
(6-fold increase in TIN2-depleted cells and 8- to 10-fold in-
crease in POT1-depleted cells) (Fig. 8). However, the DNA
damage response associated with POT1 depletion does not
disrupt recruitment of telomerase to telomeres (Fig. 4). In
addition, we found that TIFs remained in our cells rescued
with the wild-type TPP1 construct. ChIP analysis of -H2AX
suggests that the TIF formation that occurred with TPP1 de-
pletion was only partially rescued by the full-length TPP1 (or
by the TPP1OB protein) under the conditions of the exper-
iment (TPP1*; Fig. 9A and B). (The incomplete suppression of
TIFs may reflect lower expression levels of transgenic TPP1
than of endogenous TPP1 [Fig. 5A, lanes 1 and 8].) Moreover,
in microscopy experiments, 53BP1 was found at telomeres in
19%  6% (SEM) of cells rescued with full-length TPP1 (Fig.
9C) where telomerase recruitment was restored (Fig. 5 and 6)
(compared to 0.4%  0.4% [SEM] of untreated cells), sug-
gesting that the loss of telomerase recruitment is not a result of
secondary effects of TPP1 knockdown on telomere structure.
In fact, telomerase was observed at the same telomeres as the
TIF marker protein 53BP1 in the rescued cells (Fig. 9C),
clearly indicating that TIF formation does not prevent recruit-
ment of telomerase. At the same time, TIFs (indicated by the
presence of -H2AX or 53BP1 at telomeres) were present in
FIG. 7. DNA damage response at telomeres following TPP1 depletion. (A) ChIP of telomeric and Alu DNA with -H2AX antibodies.
Transfected plasmids are indicated. (B) The graph represents the quantification of the dot blot indicating the percentages of telomeric and
Alu DNA recovered with -H2AX antibodies. Error bars correspond to standard deviations of four independent experiments. Statistical
analyses were done using a two-tailed Student’s t test (, P 
 0.01). (C) Immunoblot was probed with anti--H2AX and CENP-A antibodies
following transfection of super-telomerase HeLa cells with empty vector or TPP1 shRNA construct as indicated. (D) TPP1-depleted cells
were subjected to FISH and IF to label for telomeres (green) and 53BP1 (TIF marker, red). Merge panels show superimposition of telomeres
and 53BP1 (colocalizations are indicated by yellow).
FIG. 8. Increased DNA damage response at telomeres upon
TIN2 or POT1 depletion. (A) ChIP of telomeric and Alu DNA with
-H2AX antibodies. (B) The graph represents the quantification of
the dot blot. Error bars correspond to standard deviations of results
of two independent experiments.
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cells depleted of TPP1 (Fig. 7) or expressing the TPP1OB
protein (Fig. 9), indicating that the DNA damage response
at telomeres also does not stimulate telomerase recruitment
in the absence of intact TPP1. The results indicate that the
association of telomerase with telomeres depends on TPP1
and, in particular, on the OB-fold domain of TPP1.
DISCUSSION
It is now clear that one primary mechanism for the regula-
tion of telomerase activity is through regulated intracellular
trafficking of the enzyme (23, 43, 44). Accumulation of hTR in
Cajal bodies is mediated by TCAB1 and is required to render
telomerase competent for association with telomeres in the S
phase of the cell cycle (12, 46). The factors responsible for the
recruitment of telomerase to telomeres have remained uniden-
tified. In this study, using combined FISH and ChIP analysis,
we have determined that depletion of shelterin proteins TPP1
and TIN2 (but not POT1) prevents association of telomerase
with telomeres (Fig. 1 and 3). These findings indicate that the
majority of telomerase is recruited to telomeres by TPP1,
FIG. 9. The presence of TIFs (telomere dysfunction-induced foci) does not impact the ability of TPP1 to rescue telomerase associations with
telomeres. (A) ChIP of telomeric and Alu DNA with -H2AX antibodies. Transfected plasmids are indicated. Expression of TPP1* and TPP1OB*
partially rescues TIF formation observed in TPP1-depleted cells. (B) The graph represents the quantification of the dot blot indicating the percentages
of telomeric and Alu DNA recovered with -H2AX antibodies. Error bars correspond to standard deviations of results of four independent experiments.
Statistical analyses were done using a two-tailed Student’s t test (***, P
 0.001; **, P
 0.01). (C) Although TIFs were detected in TPP1-depleted cells
coexpressing TPP1* or TPP1OB*, TIFs did not inhibit rescue of hTR recruitment to telomeres by TPP1*. Super-telomerase HeLa cells were
cotransfected with shTPP1 and either TPP1* or TPP1OB*. Treated cells were subjected to FISH and IF to label for hTR (red), FLAG (blue), 53BP1
(green), and telomeres (green). Merge panels show superimposition of hTR, 53BP1, and FLAG or hTR, telomeres, and FLAG.
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which is bound to telomeres via TIN2 in humans and likely
other vertebrates (see Fig. 1A).
TPP1 could theoretically function in telomerase recruitment
specifically when bound to the single-stranded 3 region of the
telomere via POT1 (14, 16, 38, 51) (Fig. 1A). Indeed, TPP1 has
been speculated to function with POT1 to recruit telomerase
(52). However, we did not detect significant changes in telo-
merase recruitment upon depletion of POT1 (Fig. 4), indicat-
ing that interaction with POT1 and the single-stranded end of
the telomere is not required for recruitment of telomerase to
telomeres by TPP1. At the same time, our results do not
exclude the possibility that POT1 also plays an important role
(positive or negative) in telomerase recruitment. The single-
stranded 3 overhang of the telomere is generally much less
extensive (typically 0.1 to 0.3 kb) than the double-stranded
tract (typically 2 to 20 kb), and thus the fraction of telomerase
that may be present at the 3 overhang would be expected to be
small relative to that bound to the double-stranded part of the
telomere. A specific change in telomerase levels at the single-
stranded end may be difficult to detect above the background
of telomerase associated with the rest of the telomere. Logi-
cally, the association of telomerase with the single-stranded
region of the telomere is important for telomere elongation.
Recruitment of telomerase to the double-stranded part of the
telomere may anticipate its catalytic action at the 3 end, per-
haps by increasing the local concentration of telomerase. Im-
portantly, the previously described S-phase-specific trafficking
of telomerase to telomeres (23, 43, 44) is TIN2-TPP1 depen-
dent (Fig. 1D and E), indicating that TIN2-TPP1-mediated
recruitment is regulated by the cell cycle. While we cannot
formally exclude an independent role for TPP1 and/or TIN2 in
telomerase recruitment (since depletion of one is accompanied
by reduction of the other [Fig. 2A and B]), current knowledge
about the organization of the shelterin complex supports co-
function in the form of TIN2-anchored TPP1 (16, 51). The
significance of telomerase association with telomeres via TIN2-
TPP1 is indicated by the recent identification of TIN2 muta-
tions in patients suffering from the short telomere disease
dyskeratosis congenita (39). Our findings suggest that ineffi-
cient telomerase recruitment might contribute to the patho-
genesis of dyskeratosis congenita in these patients. It is not yet
known whether additional factors are involved in TIN2-TPP1-
mediated recruitment of telomerase to telomeres. It was pre-
viously demonstrated that TPP1 associates with telomerase in
cell extracts (52); however, it is not clear whether TPP1 inter-
acts directly with telomerase.
The results presented here support the emerging view that
certain shelterin components act as both negative and positive
regulators of telomerase function (14, 40, 48, 52). While col-
lectively the shelterin proteins inhibit telomerase-telomere in-
teractions, evidence indicates that particular telomere-associ-
ated proteins can also interact with and recruit telomerase.
These proteins include Cdc13 (Saccharomyces cerevisiae),
TEBP-beta (ciliates), and TPP1 (humans and other vertebrates
[this study]) (9, 31, 35–37, 48, 52). Recent studies indicate that
dynamic phosphorylation of these proteins switches them be-
tween negative and positive regulation of telomerase recruit-
ment by modulating the ability of the protein to interact with
specific partner proteins. For example, in yeast, phosphor-
ylation of Cdc13 by CDK1 favors an interaction with the Est1
subunit of telomerase (telomerase recruitment) over interac-
tion with Stn1/Ten1 proteins (end protection) (30, 45). Like-
wise, in ciliates, phosphorylation of TEBP-beta stimulates the
function of the protein in telomerase recruitment and inter-
feres with formation of a heterodimer with TEBP-alpha, which
functions in telomere protection (36). TPP1 is a structural
homolog of the ciliate TEBP-beta protein (48, 52) and contains
a conserved serine-rich domain with several predicted Cdk2
phosphorylation sites (48, 52). Our findings establish TPP1 as
a central factor in telomerase recruitment in humans. While
depletion of TPP1 reduces telomerase recruitment (this study),
it can also lead to telomerase-mediated telomere extension
(33, 54), suggesting that TPP1 is also poised to function as part
of telomerase repressing and activating complexes in humans.
To fully understand the mechanisms that underlie telomerase
recruitment and understand the positive and negative roles of
TPP1, POT1, and other shelterin components in telomerase
regulation, it will be important to delineate the various telo-
meric states, identify the components of telomerase that asso-
ciate with TPP1 during recruitment, and investigate whether
phosphorylation of TPP1 plays a role in the regulated recruit-
ment of telomerase to telomeres.
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